Gilead Sciences (GILD)

$110.41 1.12 (1.00%)

14:05 EST GILD Stock Quote Delayed 30 Minutes

10 Best Stocks to Buy to Build Up Passive Income Streams

By Ian Bezek, InvestorPlace Contributor Jun 24, 2021

These income stocks boast huge dividend growth rates and should generate large passive income streams over the next decade.

7 Former Pandemic Stocks to Buy That Are No Longer Running Hot

2 Must-Own Biotech Stocks to Buy in May

Vaccitech IPO: When Does Vaccitech Go Public? What Is the VACC Stock IPO Price Range?

Volume:

Previous Close -

Market Cap 138.43B

PE Ratio 1,380.13

EPS 0.08

Volume (Avg. Vol.) 3.01M

Day's Range $108.40 - $111.07

52-Week Range $62.07 - $112.11

Dividend & Yield $3.08 (2.79%)

GILD Stock Predictions, Articles, and Gilead Sciences News

7 Pharmaceutical Stocks With Dividends in Hand

By Thomas Niel, InvestorPlace Contributor Apr 28, 2021

So, which pharmaceutical stocks should be on your radar, if dividends are a top priority? Consider these seven compelling opportunities.

7 Healthcare Stocks for a Reopening World

By Tezcan Gecgil, InvestorPlace Contributor Apr 26, 2021

The stock market is at all-time highs, and the world is starting to reopen. But these healthcare stocks have more growth opportunities ahead.

7 Healthcare Stocks to Buy to Prepare Your Portfolio For The Next Pandemic

By Tezcan Gecgil, InvestorPlace Contributor Apr 1, 2021

Covid-19 has put healthcare stocks in the limelight. These seven companies should be on your radar for the next pandemic.

7 Value Stocks Everyone Is Ignoring

By Tezcan Gecgil, InvestorPlace Contributor Mar 24, 2021

Blue chips and companies on the rebound. Here are seven of the best value stocks for long-term investors.

7 High-Yield Stocks for Your Retirement Nest Egg

By Tom Taulli, InvestorPlace Contributor Mar 15, 2021

High-dividend names are some of the best retirement stocks and can be a good way to achieve strong long-term growth for your portfolio.

3 Deep Value Stocks for Income and High Total Returns

By Bob Ciura, Sure Dividend Mar 11, 2021

Look to these value stocks for a great blend of dividend safety, payout growth, current yield and capital appreciation potential.

7 Pharmaceutical Stocks With Compelling Pipelines

By Chris Lau, InvestorPlace Contributor Feb 2, 2021

Covid-19 vaccines are getting all the glory after multi-bagger returns last year but these seven pharmaceutical stocks have a strong future ahead.

5 Undervalued Dividend Stocks to Buy

By Thomas Niel, InvestorPlace Contributor Dec 31, 2020

With markets at record highs and interest rates at record lows, consider these five dividend stocks to buy for value and yield.

3 Cheap Stocks Worth Buying Right Now

By Chris Tyler, InvestorPlace Contributor Dec 2, 2020

Cheap stocks can come with many caveats. But sometimes, and as these three companies shares point at, they come equipped with some real value.

Pfizer, Moderna Lead the Vaccine Race: Here’s Where 7 Other Top Vaccine Stocks Stand

By Josh Enomoto, InvestorPlace Contributor Nov 24, 2020

As Pfizer and Moderna take the lead in the novel coronavirus vaccine race, here’s how this affects other Covid-19-related biotech stocks.

4 Top Biotech Stocks to Buy for Operation Warp Speed

By Joel Baglole, InvestorPlace Contributor Nov 3, 2020

The U.S. government has pulled out all the stops to develop a treatment for Covid-19. These biotech stocks are leading the race for a cure.

Which Biotech Stocks Are a Buy on Earnings?

By Louis Navellier, Editor, Growth Investor Nov 3, 2020

If you’re interested in high-growth biotech stocks with superior fundamentals, here are which ones to consider, and which ones to skip.

4 Top Stock Trades for Monday: TWLO, SNAP, SPAQ, GILD

By Bret Kenwell, InvestorPlace Contributor Oct 23, 2020

Twilio, Gilead Sciences, Snap and Spartan Energy Acquisition are our top stock trades to watch on Monday. And here's why.

Gilead Stock: 12 Things for Investors to Know About Remdesivir Approval

By Sarah Smith, Editor-in-Chief, InvestorPlace.com Oct 23, 2020

Want to know what the big remdesivir approval actually means for Gilead stock? Here's everything investors need to understand.

GILD News: Gilead Stock Pops as FDA Approves Remdesivir Treatment

By Sarah Smith, Editor-in-Chief, InvestorPlace.com Oct 22, 2020

Gilead stock is climbing higher Thursday after its remdesivir coronavirus treatment received full approval from the FDA. Why it matters.

9 Stocks to Buy for a Wild Ride in November

By Josh Enomoto, InvestorPlace Contributor Oct 15, 2020

With rising coronavirus hospitalizations dominating headlines, investors will shift back toward a pandemic mentality. Here are nine stocks to buy to capitalize on this trend.

7 Highly Rated Pharmaceutical Stocks for Q4

By Joel Baglole, InvestorPlace Contributor Oct 12, 2020

Investors are banking on an upsurge in pharmaceutical stocks once various vaccines and other therapies gain commercial approval from the U.S. Food and Drug Administration (FDA). Here is a list of pharmaceutical companies that stand to benefit in the coming months.

Gilead Sciences (GILD)

10 Best Stocks to Buy to Build Up Passive Income Streams

7 Former Pandemic Stocks to Buy That Are No Longer Running Hot

2 Must-Own Biotech Stocks to Buy in May

Vaccitech IPO: When Does Vaccitech Go Public? What Is the VACC Stock IPO Price Range?

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Gilead Sciences (GILD)

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

GILD Stock Predictions, Articles, and Gilead Sciences News

Subscriber Sign in